Emerald Advisers, LLC Ani Pharmaceuticals Inc Transaction History

Emerald Advisers, LLC

$2.53 Billion
Q2 2025

A detailed history of Emerald Advisers, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,256 shares of ANIP stock, worth $119,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,256

Previous 244 414.75%

Holding current value

$119,470

Previous $16,000 406.25%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$57.79 - $72.95 $58,483 - $73,825	1,012 Added 414.75%	1,256 $81,000
Q4 2023 Feb 05, 2024	SELL	$48.72 - $65.43 $8.48 Million - $11.4 Million	-174,033 Reduced 99.86%	244 $13,000
Q3 2023 Oct 26, 2023	BUY	$50.28 - $64.61 $50 - $64	1 Added 0.0%	174,277 $10.1 Million
Q2 2023 Jul 25, 2023	SELL	$37.29 - $53.83 $7.43 Million - $10.7 Million	-199,130 Reduced 53.33%	174,276 $9.38 Million
Q1 2023 May 04, 2023	SELL	$37.61 - $45.72 $2.63 Million - $3.19 Million	-69,830 Reduced 15.75%	373,406 $14.8 Million
Q4 2022 Feb 03, 2023	SELL	$31.9 - $41.95 $431,032 - $566,828	-13,512 Reduced 2.96%	443,236 $17.8 Million
Q3 2022 Oct 25, 2022	BUY	$29.83 - $38.01 $25,892 - $32,992	868 Added 0.19%	456,748 $14.7 Million
Q2 2022 Jul 29, 2022	BUY	$23.09 - $33.46 $2.35 Million - $3.41 Million	101,835 Added 28.76%	455,880 $13.5 Million
Q1 2022 Apr 29, 2022	BUY	$26.91 - $47.15 $7.3 Million - $12.8 Million	271,101 Added 326.85%	354,045 $9.95 Million
Q4 2021 Feb 02, 2022	BUY	$32.97 - $56.85 $2.73 Million - $4.72 Million	82,944 New	82,944 $3.82 Million

Others Institutions Holding ANIP

# of Institutions

246

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.66B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Ani Pharmaceuticals Inc Transaction History